Evaluation of the applicability of HRT as a preservative of muscle strength in women

Maturitas

Volumn 36, Issue 1, 2000, Pages 49-61

  Meeuwsen, Ingrid B ^a   Samson, Monique M ^a   Verhaar, Harald J ^a  

^a Univ H   (Netherlands)

Author keywords

Hormone replacement therapy; Menopause; Review; Skeletal muscle; Strength

Indexed keywords

ESTROGEN; GESTAGEN;

AGE; BODY EQUILIBRIUM; DRUG MECHANISM; FALLING; FEMALE; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MENOPAUSE; MUSCLE STRENGTH; NORMAL HUMAN; PHYSICAL ACTIVITY; REVIEW; SEX DIFFERENCE; SKELETAL MUSCLE;

EID: 0034738345     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(00)00132-8     Document Type: Article

References (108)

1. Samson MM, Meeuwsen IBAE, Crowe A, Dessens JAG, Duursma SA, Verhaar HJJ. Differences in variables of muscle strength and functional mobility in healthy subjects in relation to age, height and body weight. Age Ageing. 29:2000;235-242.
2. Phillips S.K., Rook K.M., Siddle N.C., Bruce S.A., Woledge R.C. Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin. Sci. (Colch.). 84:1993;95-98.
3. Kallman D.A., Plato C.C., Tobin J.D. The role of muscle loss in the age-related decline of grip strength: cross-sectional and longitudinal perspectives. J. Gerontol. 45:1990;M82-M88.
4. Speroff L. Menopause and hormone replacement therapy. Clin. Geriatr. Med. 9:1993;33-55.
5. Chamay A., Tschantz P. Mechanical influences in bone remodeling. Experimental research on Wolff's law. J. Biomech. 5:1972;173-180.
6. Osei-Hyiaman D., Ueji M., Toyokawa S., Takahashi H., Kano K. Influence of grip strength on metacarpal bone mineral density in postmenopausal Japanese women: a cross-sectional study. Calcif. Tissue Int. 64:1999;263-266.
7. Nelson M.E., Fiatarone M.A., Morganti C.M., Trice I., Greenberg R.A., Evans W.J. Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. A randomized controlled trial. J. Am. Med. Assoc. 272:1994;1909-1914.
8. Schiessl H., Frost H.M., Jee W.S.S. Estrogen and bone-muscle strength and mass relationships. Bone. 22:1998;1-6.
9. Skelton D.A., Young A., Greig C.A., Malbut K.E. Effects of resistance training on strength, power, and selected functional abilities of women aged 75 and older. J. Am. Geriatr. Soc. 43:1995;1081-1087.
10. Judge J.O., Underwood M., Gennosa T. Exercise to improve gait velocity in older persons. Arch. Phys. Med. Rehabil. 74:1993;400-406.
11. Harridge S.D., Kryger A., Stensgaard A. Knee extensor strength, activation, and size in very elderly people following strength training. Muscle Nerve. 22:1999;831-839.
12. Schulz R., Curnow C. Peak performance and age among superathletes: track and field, swimming, baseball, tennis and golf. J. Gerontol. 43:1988;P113-P120.
13. Dishman R.K. Motivating older adults to exercise. Sount. Med. J. 87:1994;S79-S82.
14. Lamberts S.W.J., Beld van den A.W., Lely van der A.-J. The endocrinology of aging. Science. 278:1997;419-424.
15. Morales A.J., Haubrich R.H., Hwang J.Y., Asakura H., Yen S.S. The effect of six months treatment with a 100mg daily dose of dehydroepiandrosterone (DHEA) on circulatory sex steroids, body composition and muscle strength in age-advanced men and women. Clin. Endocrinol. (Oxf.). 49:1998;421-432.
16. Mauras N., Hayes V., Welch S. et al. Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength and adiposity. J. Clin. Endocrinol. Metab. 83:1998;1886-1892.
17. Gustafsson J.A., Saartok T., Dahlberg E., Snochowski M., Häggmark T., Eriksson E. Studies on steroid receptors in human and rabbit skeletal muscle - clues to the understanding of the mechanism of action of anabolic steroids. Prog. Clin. Biol. Res. 142:1984;261-290.
18. Wainman P., Shipounoff G.C. The effects of castration and testosterone propionate on the striated perineal musculature in the rat. Endocrinology. 58:1941;231.
19. Wren B.G. The menopause. Hacker N.F., Moore J.G. Essentials of Obstetrics and Gynecology. 1992;543-550 WB Saaunders, Philadelphia.
20. Corpas E., Harman S.M., Blackman M.R. Human growth hormone and human aging. Endocr. Rev. 14:1993;20-39.
21. Ravaglia G., Forti P., Maioli F., Boschi F., Bernardi M., Pratelli L., Pizzoferrato A., Gasbarrine G. The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine metabolic parameters and functional status in the oldest-old. Results from an Italian study on helathy free-living over-ninety-year-olds. J. Clin. Endocrinol. Metab. 81:1996;1173-1178.
22. Rooyackers O.E., Nair K.S. Hormonal regulation of human muscle protein metabolism. Annu. Rev. Nutr. 17:1997;457-485.
23. Edström L., Grimby L. Effect of exercise on the motor unit. Muscle Nerve. 9:1986;104-126.
24. Karpovich P.V. Coordination of functions of various organs for muscular work. Physiology of Muscular Activity. 1966;190-197 W.B. Saunders, Philadelphia.
25. Timiras P.S. Degenerative changes in cells and cell death. Developmental Physiology and Aging. 1972;Macmillan, New York.
26. Larsson L., Grimby G., Karlsson J. Muscle strength and speed of movement in relation to age and muscle morphology. J. Appl. Physiol. 46:1979;451-456.
27. Grimby G., Saltin B. Mini-review: the ageing muscle. Clin. Physiol. 3:1983;209-218.
28. Jones D.A., Round J.M. Innervation and electrical activity. Skeletal Muscle in Health and Disease. A Textbook of Muscle Physiology. 1990;41-54 Manchester university press, Manchester, UK.
29. Bassey E.J., Harries U.J. Normal values for handgrip strength in 920 men and women aged over 65 years, and longitudinal changes over 4 years in 620 survivors. Clin. Sci. Colch. 84:1993;331-337.
30. Narici M.V., Bordini M., Cerretelli P. Effect of aging on human adductor pollicis muscle function. J. Appl. Physiol. 71:1991;1277-1281.
31. Overstall P.W., Exton-Smith A.N., Imms F.J., Johnson A.L. Falls in the elderly related to postural imbalance. Br. Med. J. 1:1977;261-264.
32. Era P., Heikkinen E. Postural sway during standing and unexpected disturbance of balance in random samples of men of different ages. J. Gerontol. 40:1985;287-295.
33. Blake A.J., Morgan K., Bendall M.J. et al. Falls by elderly people at home: prevalence and associated factors. Age Ageing. 17:1988;365-372.
34. Wickham C., Cooper C., Margetts B.M., Barker D.J. Muscle strength, activity, housing and the risk of falls in elderly people. Age Ageing. 18:1989;47-51.
35. Kochakian C.D. Protein anabolic property of androgens. Ala. J. Med. Sci. 1:1964;24.
36. Mainwaring W.I.P. The mechanism of action of androgens. Monographs on Endocrinology. 10:1977;Springer, New York.
37. Chainy G.B., Kanungo M.S. Effects of estradiol and testosterone on the activity of pyruvate kinase of the cardiac and skeletal muscles of rats as a function of age and sex. Biochim. Biophys. Acta. 540:1978;65-72.
38. Hanzliková V., Gutmann E. Effect of castration and testosterone administration on the neuromuscular junction in the levator ani muscle. Cell. Tissue Res. 189:1978;155-166.
39. Kahlert S., Grohé C., Karas R.H., Löbbert K., Neyses L., Vetter H. Effects of estrogen on skeletal myoblast growth. Biochem. Biophys. Res. Commun. 232:1997;373-378.
40. Elsasser T.H., Rumsey T.S., Kahl S. et al. Effects of Synovex-S and recombinant bovine growth hormone (Somavubove) on growth responses of steers: III. Muscle growth and protein responses. J. Anim. Sci. 76:1998;2346-2353.
41. Lu FC, Rendel J. Anabolic agents in animal production: FAO\WHO symposium Rome, March 1975. In: Lu Fch and Rendel J, editors. Environmental Quality and Safety, vol. 5. Stuttgart: Thieme Verlag, 1976.
42. Heitzman R.J. The efficacy and mechanism of action of anabolic agents as growth promoters in farm animals. J. Steroid Biochem. 11:1979;927-930.
43. Suzuki S., Yamamuro T. Long-term effects of estrogen on rat skeletal muscle. Exp. Neurol. 87:1985;291-299.
44. Phillips S.K., Sanderson A.G., Birch K., Bruce S.A., Woledge R.C. Changes in maximal voluntary force of human adductor pollicis muscle during the menstrual cycle. J. Physiol. (Lond.). 496:1996;551-557.
45. Petrofsky J.S., LeDonne D.M., Rinehart J.S., Lind A.R. Isometric strength and endurance during the menstrual cycle. Eur. J. Appl. Physiol. 35:1976;1-10.
46. Sarwar B., Beltran Niclos B., Rutherford O.M. Changes in muscle strenght, relaxation rate and fatiguability during the human menstrual cycle. J. Phys. (Lond.). 493:1996;267-272.
47. Landgren B.M., Unden A.L., Diczfalusy E. Hormonal profile of the cycle in 68 normally menstruating women. Acta Endocrinol. (Copenh.). 94:1980;89-98.
48. Dawson P.M. Tests. The Physiology of Physical Education. 1935;816-817 Williams and Wilkins, Baltimore.
49. Florini J.R. Hormonal control of muscle growth. Muscle Nerve. 10:1987;577-598.
50. Nicklas B.J., Hackney A.C., Sharp R.L. The menstrual cycle and exercise: performance, muscle glycogen and substrate responses. Int. J. Sports Med. 10:1989;264-269.
51. Speroff L., Glass R.H., Kase N.G. Hormone biosynthesis, metabolism and mechanism of action. Clinical Gynecologic Endocrinology and Infertility. 5th edition:1994;Williams & Wilkins, Baltimore.
52. Lebrun C.M., McKenzie D.C., Prior J.C., Taunton J.E. Effects of menstrual cycle phase on athletic performance. Med. Sci. Sports Exerc. 27:1995;437-444.
53. DiBrezzo R., Fort I.L., Brown B. Relationships among strength, endurance, weight and body fat during three phases of the menstrual cycle. J. Sports Med. Phys. Fitness. 31:1991;89-94.
54. Greeves J.P., Cable N.T., Luckas M.J., Reilly T., Biljan M.M. Effects of acute changes in oestrogen on muscle function of the first dorsal interosseus muscle in humans. J. Physiol. (Lond.). 500:1997;265-270.
55. Bassey E.J., Coates L., Culpan J., Littlewood J.J., Owen M., Wilson K. Natural variations in oestrogen and FSH levels in eumenorrheic women in negative association with voluntary muscle strength. J. Physiol. (Lond.). 489:1995;28P.
56. Davies B.N., Elford J.C., Jamieson K.F. Variations in performance in simple muscle tests at different phases of the menstrual cycle. J. Sports Med. Phys. Fitness. 31:1991;532-537.
57. Saunders P.T., Fisher J.S., Sharpe R.M., Miller M.R. Expression of oestrogen receptor beta (ERβ) occurs in multiple cell types, including some germ cells, in the rat testis. J. Endocrinol. 156:1998;R13-R17.
58. Panno M.L., Sisci D., Salerno M. et al. Thyroid hormone modulates androgen and oestrogen receptor content in the Sertoli cells of peripubertal rats. J. Endocrinol. 148:1996;43-50.
59. Dubé J.Y., Lesage R., Tremblay R.R. Androgen and estrogen binding in the rat skeletal and perineal muscles. Can. J. Biochem. 54:1976;50-55.
60. Dahlberg E. Characterization of the cytosolic estrogen receptor in rat skeletal muscle. Biochim. Biophys. Acta. 717:1982;65-75.
61. Seiki K., Imanishi Y., Haruki Y. Accumulation and binding of 3H-estradiol-17beta by lymphoid tissues of castrated mice. Endocrinol. Jpn. 25:1978;289-294.
62. Sauerwein H., Meyer H.H. Androgen and estrogen receptors in bovine skeletal muscle: relation to steroid-induced allometric muscle growth. J. Anim. Sci. 67:1989;206-212.
63. Saartok T. Steroid receptors in two types of rabbit skeletal muscle. Int. J. Sports Med. 5:1984;130-136.
64. Koligian K.B., Stormshak F. Nuclear and cytoplasmic estrogen receptors in ovine endometrium during the estrous cycle. Endocrinology. 101:1977;524-533.
65. Michel G., Baulieu E.E. Androgen receptor in rat skeletal muscle: characterization and physiological variation. Endocrinology. 107:1980;2088-2098.
66. Lievertz R.W. Pharmacology and pharmacokinetics of estrogens. Am. J. Obstet. Gynecol. 156:1987;1289-1293.
67. Saartok T., Dahlberg E., Bylund P., Eriksson E., Gustafsson J.A. Steroid hormone receptors, protein and DNA in erector spinae muscle from scoliotic patients. Clin. Orthop. 183:1984;197-207.
68. Snochowski M., Saartok T., Dahlberg E., Eriksson E., Gustafsson J.A. Androgen and glucocorticoid receptors in human skeletal muscle cytosol. J. Steroid. Biochem. 14:1981;765-771.
69. Massafra C., De Felice C., Agnusdei D.P., Gioia D., Bagnoli F. Androgens and osteocalcin during the menstrual cycle. J. Clin. Endocrinol. Metab. 84:1999;971-974.
70. Tenover J.S. Androgen administration to aging men. Endocrinol. Metab. Clin. North Am. 23:1994;877-892.
71. Swerdloff R.S., Wang C. Androgen deficiency and aging in men. West. J. Med. 159:1993;579-585.
72. Morley J.E., Perry H.M. 3rd, Kaiser F.E. et al. Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J. Am. Geriatr. Soc. 41:1993;149-152.
73. Erfurth E.M., Hagman L.E., Saaf M., Hall K. Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein 1 correlate with serum free testosterone and sex hormone binding globulin levels in healthy young and middle-aged men. Clin. Endocrinol. (Oxf.). 44:1996;659-664.
74. Ala-Fossi S.L., Mäenpää J., Bläuer M., Aine R., Tuohimaa P., Punnonen R. Inhibin A and B in peri- and postmenopause. Maturitas. 30:1998;273-281.
75. Beld van den A.W., Huhtaniemi I.T., Pettersson K.S.L., Pols H.A.P., Grobbee D.E., Jong de F.H., Lamberts S.W.J. Luteinizing hormone and different genetic variants, as indicators of frailty in healthy elderly men. J. Clin. Endocrinol. Metab. 84:1999;1334-1339.
76. Kerrigan J.R., Rogol A.D. The impact of gonadal steroid hormone action on growth hormone secretion during childhood and adolescence. Endocr. Rev. 13:1992;281-298.
77. Faria A.C.S., Bekenstein L.W., Booth R.A. Jr, Vaccaro V.A., Asplin C.M., Veldhuis J.D., Thorner M.O., Evans W.S. Pulsatile growth hormone release in normal women during the menstrual cycle. Clin. Endocrinol. 36:1992;591-596.
78. Shah N., Evans W.S., Veldhuis J.D. Actions of estrogen on pulsatile, nyctohemeral, and entropic modes of growth hormone secretion. Am. J. Physiol. 276:1999;R1351-R1358.
79. Fröhlander N., Schultz von B. Growth hormone and somatomedin C during postmenopausal replacement therapy with oestrogen alone and in combination with an antioestrogen. Maturitas. 9:1988;297-302.
80. Weissberger A.J., Ho K.K.Y., Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor 1, and GH-binding protein in postmenopausal women. J. Clin. Endocrinol. Metab. 72:1991;374-381.
81. Cano A., Castelo-Branco C., Tarín J.J. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insuline-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels. Fertil. Steril. 71:1999;261-267.
82. Moe K.E., Prinz P.N., Larsen L.H., Vitiello M.V., Reed S.O., Merriam G.R. Growth hormone in postmenopausal women after long-ter, oral estrogen replacement therapy. J. Gerontol. 53A:1998;B117-B124.
83. Murphy L.J., Friesen H.G. Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor 1 gene expression in the ovariectomized hypophyectomized rat. Endocrinology. 122:1988;325-332.
84. Bellantoni M.F., Vittone J., Campfield A.T., Bass K.M., Harman S.M., Blackman M.R. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor 1 axis in younger and older postmenopausal women: a clinical research center study. J. Clin. Endocrinol. Metab. 81:1996;2848-2853.
85. Cauley J.A., Gutai J.P., Kuller L.H., LeDonne D., Powell J.G. The epidemiology of serum sex hormones in postmenopausal women. Am. J. Epidemiol. 129:1989;1120-1131.
86. Greeves J.P., Cable N.T., Reilly T., Kingsland C. Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy. Clin. Sci. (Colch.). 97:1999;79-84.
87. Heikkinen J., Kyllönen E., Kurtilla-Matero E. et al. HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women. Maturitas. 26:1997;139-149.
88. Skelton D.A., Phillips S.K., Bruce S.A., Naylor C.H., Woledge R.C. Hormone replacement therapy increases muscle strength of the adductor pollicis in post-menopausal women. Clin. Sci. (Colch.). 96:1999;357-364.
89. Cauley J.A., Petrini A.M., LaPorte R.E. et al. The decline of grip strength in the menopause: relationship to physical activity, estrogen use and anthropometric factors. J. Chronic Dis. 40:1987;115-120.
90. Skelton DA, Phillips SK, Bruce SA, Naylor CH, Woledge RC. Hormone replacement therapy increases muscle strength. Abstract C149 at Cambridge Meeting, 15-17 December, 1997. Hum Phys 1997;127P.
91. Preisinger E., Alacamlioglu Y., Saradeth T., Resch K.L., Holzer G., Metka M. Forearm bone density and grip strenght in women after menopause, with and without estrogen replacement therapy. Maturitas. 21:1995;57-63.
92. Seeley D.G., Cauley J.A., Grady D., Browner W.S., Nevitt M.C., Cummings S.R. Is postmenopausal estrogen therapy associated with neuromuscular function or falling in elderly women? Study of Osteoporotic Fractures Research Group. Arch. Intern. Med. 155:1995;293-299.
93. Armstrong A.L., Oborne J., Coupland C.A., MacPherson M.B., Bassey E.J., Wallace W.A. Effects of hormone replacement therapy on muscle performance and balance in post-menopausal women. Clin. Sci. (Colch.). 91:1996;685-690.
94. Taaffe D.R., Luz Villa M., Delay R., Marcus R. Maximal muscle strength of elderly women is not influenced by oestrogen status. Age Ageing. 24:1995;329-333.
95. Brown M., Birge S.J., Kohrt W.M. Hormone replacement therapy does not augment gains in muscle strength or fat-free mass in response to weight-bearing exercise. J. Gerontol. 52:1997;B166-B170.
96. Bassey EJ, Rothwell MC, Littlewood JJ, Pye DW. Comparison of muscle strength and balance in post-menopausal women between those on HRT and those who were oestrogen deplete. Abstract PC35 at Cambridge Meeting, 15-17 December, 1997.
97. Ettinger B., Grady D. The waning effect of postmenopausal oestrogen therapy on osteoporosis. N. Engl. J. Med. 329:1993;1192-1193.
98. Felson D.T., Zhang Y., Hannan M.T., Kiel D.P., Wilson P.W., Anderson J.J. The effect of postmenopausal estrogen therapy on bone density in elderly women. N. Engl. J. Med. 329:1993;1141-1146.
99. Bohannon R.W. Intertester reliability of hand-held dynamometry: a concise summary of published research. Percept. Mot. Skills. 88:1999;899-902.
100. Naessen T., Lindmark B., Larsen H.C. Better postural balance in elderly women receiving estrogens. Am. J. Obstet. Gynecol. 177:1997;412-416.
101. Hammar M.L., Lindgren R., Berg G.E., Moller C.G., Niklasson M.K. Effects of hormonal replacement therapy on the postural balance among postmenopausal women. Obstet. Gynecol. 88:1996;955-960.
102. Goebel J.A., Birge S.J., Price S.C., Hanson J.M., Fishel D.G. Estrogen replacement therapy and postural stability in the elderly. Am. J. Otol. 16:1995;470-474.
103. Duval D., Durant S., Homo-Delarche F. Non-genomic effects of steroids. Interactions of steroid molecules with membrane structures and functions. Biochim. Biophys. Acta. 737:1983;409-442.
104. Van Hoof H.J., van der Mooren M.J., Swinkels L.M., Sweep C.G., Merkus J.M., Benraad T.J. Female sex hormone replacement therapy increases serum free 1, 25-dihydroxy vitamin D3: a 1-year prospective study. Clin. Endocrinol. (Oxf.). 50:1999;511-516.
105. Cheema C., Grant B.F., Marcus R. Effects of estrogen on circulating 'free' and total 1,25-dihydroxyvitamin D and on the parathyroid-vitamin D axis in postmenpausal women. J. Clin. Invest. 83:1989;537-542.
106. Bischoff H.A., Stähelin H.B., Urscheler N., Ehrsam R., Vonthein R., Perrig-Chiello P., Tyndall A., Theiler R. Muscle strength in the elderly: its relation to vitamin D metabolites. Arch. Phys. Med. Rehabil. 80:1999;54-58.
107. Moll W., Gotz R. Pressure-diameter curves of mesometrial arteries of guinea pigs demonstrate a non-muscular, oestrogen-inducible mechanism of lumen regulation. Pflugers Arch. 404:1985;332-336.
108. McEwen B.S. Gonadal steroids: humoral modulators of nerve cell function. Mol. Cell. Endocrinol. 18:1980;151-164.